P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 85,634 shares at $175.95 ($15.3M) on 2012-11-29, disclosed to the SEC on 2012-11-30.
Scheduled sale ($15.3M) by Chairman of the Board under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.03 | 7,004 | $1.2M | 8.0% |
| 2 | $175.95 | 1,800 | $317K | 2.1% |
| 3 | $176.54 | 5,100 | $900K | 5.9% |
| 4 | $177.09 | 4,402 | $780K | 5.1% |
| 5 | $178.71 | 18,440 | $3.3M | 21.5% |
| 6 | $179.60 | 19,733 |
| $3.5M |
| 23.1% |
| 7 | $180.59 | 12,000 | $2.2M | 14.1% |
| 8 | $181.19 | 17,155 | $3.1M | 20.3% |
| Total | $179.10 avg | 85,634 | $15.3M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |